Sun Pharma promoter Dilip Shanghvi and Associates have decided to terminate the amended and restated shareholders’ agreement with Suzlon Energy that was signed in February 2020. Suzlon Energy announced the termination in a regulatory filing and stated that there would be no impact on the company’s operations. The termination also led to the resignation of the investor group’s nominee director on Suzlon’s board, Hiten Timbadia. Dilip Shanghvi stated that while they will continue as investors in the company, they have decided to terminate the formal Shareholders’ Agreement signed in 2015. In 2015, Shanghvi had acquired a 23% stake in Suzlon Energy for Rs 1,800 crore.